Adicet Bio, Inc.
Simbolis: ACET
NASDAQ
1.69
USDRinkos kaina šiandien
-0.5143
P/E santykis
0.0002
PEG koeficientas
138.87M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Adicet Bio, Inc. (ACET) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 780.07 | 159.7 | 257.7 | 277.5 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 1.23 | 0 | 0.4 | 0.2 | ||||||||||||||||
balance-sheet.row.inventory | 6.39 | 0 | 2.6 | 4.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 3.94 | 2.6 | 0.4 | 0 | ||||||||||||||||
balance-sheet.row.total-current-assets | 791.62 | 162.3 | 261 | 282.4 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 188.76 | 44.2 | 49 | 35 | ||||||||||||||||
balance-sheet.row.goodwill | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | -0.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.85 | 0.8 | 1.2 | 2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 231.54 | 45 | 69.7 | 56.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1023.16 | 207.3 | 330.7 | 338.9 | ||||||||||||||||
balance-sheet.row.account-payables | 12.56 | 2.6 | 4.4 | 3.3 | ||||||||||||||||
balance-sheet.row.short-term-debt | 12.34 | 3.2 | 2.5 | 1.6 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 76.52 | 17.7 | 18.5 | 19.4 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 51.09 | 13.4 | 12.8 | 6.7 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 77.04 | 17.8 | 18.6 | 19.5 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 85.64 | 17.7 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.total-liab | 153.03 | 37.1 | 38.4 | 35.8 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 338.9 | ||||||||||||||||
balance-sheet.row.common-stock | 0.02 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -1302.45 | -380.8 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | -338.9 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1637.35 | 550.9 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 487.95 | 207.3 | -199.8 | -132.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 487.95 | - | - | - | ||||||||||||||||
Total Investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.total-debt | 88.86 | 20.9 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.net-debt | -691.21 | -138.8 | -236.6 | -256.6 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.66 | -142.7 | -69.8 | -62 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.1 | 6.1 | 2.6 | 1.5 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 9.71 | -34.1 | 0 | 1.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 20.26 | 20.3 | 17.1 | 12.5 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0.25 | 0.3 | 2.7 | -6.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0.2 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 2 | ||||||||||||||||
cash-flows.row.account-payables | -1.68 | -1.7 | 1.7 | 1.1 | ||||||||||||||||
cash-flows.row.other-working-capital | 1.94 | 1.9 | 0.8 | -9.2 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 12.62 | 56.5 | 2.6 | 1.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -93.72 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 10.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4.46 | -4.5 | -16.8 | -2.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.39 | 0.4 | 43.4 | 238.1 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.15 | -0.1 | -3.2 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0.08 | -0.1 | -1.9 | 4.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.24 | 0.2 | 41.5 | 242.7 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -97.94 | -97.9 | -20 | 188.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 780.07 | 159.7 | 257.7 | 277.7 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 878.01 | 257.7 | 277.7 | 88.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -93.72 | -93.7 | -44.8 | -51.1 | ||||||||||||||||
cash-flows.row.capital-expenditure | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.free-cash-flow | -98.18 | -98.2 | -61.5 | -64.1 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 25 | 9.7 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 8.14 | 6.1 | 5 | 0 | ||||||||||||||||
income-statement-row.row.gross-profit | -8.14 | -6.1 | 20 | 9.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 106.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.53 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.operating-expenses | 130.89 | 126.5 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 132.58 | 132.6 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.interest-income | 9.98 | 10 | 3.8 | 0.1 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 7.3 | 6.1 | 2.8 | -0.5 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -120.41 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -152.04 | -132.6 | -72.6 | -61.4 | ||||||||||||||||
income-statement-row.row.income-before-tax | -142.66 | -142.7 | -69.8 | -62.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.51 | 0 | -2.8 | -0.1 | ||||||||||||||||
income-statement-row.row.net-income | -141.4 | -142.7 | -67 | -62 |
Dažnai užduodami klausimai
Kas yra Adicet Bio, Inc. (ACET) bendras turtas?
Adicet Bio, Inc. (ACET) bendras turtas yra 207295000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.000.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra -2.281.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.000.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.000.
Kas yra Adicet Bio, Inc. (ACET) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra -142658000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 20924000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 126478000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 159711000.000.